CompletedPhase 3NCT02059135
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Studying Preeclampsia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- rEVO Biologics
- Principal Investigator
- Michael Paidas, MDYale New Haven Hospital
- Intervention
- Recombinant human antithrombin (ATryn)(biological)
- Enrollment
- 120 target
- Eligibility
- 16 years · FEMALE
- Timeline
- 2014 – 2016
Study locations (23)
- University of Alabama, Birmingham, Alabama, United States
- University of South Alabama, Mobile, Alabama, United States
- University of Arkansas, Little Rock, Arkansas, United States
- University of California at Irvine, Orange, California, United States
- Yale New Haven Hospital, New Haven, Connecticut, United States
- University of South Florida, Tampa, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- Norton Healthcare, Louisville, Kentucky, United States
- Oschner Baptist, New Orleans, Louisiana, United States
- Saint John Hospital and Medical Center, Detroit, Michigan, United States
- University of Mississippi Medical Center, Jackson, Mississippi, United States
- Barnes-Jewish Hospital, St Louis, Missouri, United States
- Saint Louis University School of Medicine, St Louis, Missouri, United States
- Columbia University Medical Center, New York, New York, United States
- Duke University, Durham, North Carolina, United States
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02059135 on ClinicalTrials.govOther trials for Preeclampsia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07443345Incidence of Postoperative Diaphragmatic Dysfunction in Pregnant Women With PreeclampsiaCairo University
- RECRUITINGPHASE2NCT06333652Ravulizumab in Pregnancies Complicated by Severe Hypertensive DisordersMayo Clinic
- RECRUITINGNANCT07245056Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset PreeclampsiaAnkara Etlik City Hospital
- RECRUITINGPHASE2NCT07041281Spironolactone to Improve Pregnancy-Associated Hypertension TrajectoriesMassachusetts General Hospital
- RECRUITINGNCT07485140Prevention of Preeclampsia in Denmark: A National Implementation StudyCopenhagen University Hospital at Herlev
- RECRUITINGNANCT06893510Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With PreeclampsiaIstanbul University - Cerrahpasa
- RECRUITINGNANCT07261956Lung Ultrasound for the Detection of Volume Overload in Patients With Severe PreeclampsiaSaint Thomas Hospital, Panama
- RECRUITINGNANCT07265336Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant WomenSaint Thomas Hospital, Panama